A reduced HDL-Cholersterol and increased triglyzerides are an often seen laboratory abnormality. They are known risk factors for arteriosclerosis. However the small influence of a pharamcologic treatment on the two reduced the interest in them. We therefore want to show the relation of the triglyzerides with the HDL-Cholesterol and the nonpharmacologic treatment of these two factors. Some clinical examples are illustrating the topic.
